Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000018

Options or other derivatives

  • Director acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DeSilva Nishan M · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-03 Grant or award : show line 1 in the form Stock Option (Right to Buy) +40,000 40,000 D
Loading xslF345X03/wf-form4_164141836846044.xml…